...
首页> 外文期刊>World Journal of Oncology >Papillary Renal Cell Carcinoma Presented With Supraclavicular Lymph Node Metastasis Without Renal Primary Lesion
【24h】

Papillary Renal Cell Carcinoma Presented With Supraclavicular Lymph Node Metastasis Without Renal Primary Lesion

机译:乳头状肾细胞癌伴锁骨上淋巴结转移无肾原发性病变

获取原文

摘要

Renal cell carcinoma is a rare cancer in Thailand. Most of the patients present in advanced metastatic stage with identifiable renal mass. In this case report, we presents a case of male patient who manifested with supraclavicular lymph node enlargement and CT scan of chest and abdomen showed multiple sites lymph node metastasis but there was no primary mass detected anywhere. The pathology of supraclavicular lymph node was papillary cell adenocarcinoma. The differential diagnoses were papillary thyroid cancer, gastrointestinal tract carcinoma such as pancreato-biliary cancer, non small cell lung cancer, and renal cancer. Immunohistochemistry result were negative for TTF-1, Thyroglobulin, CD7 and CD20 which ruled out non-small cell lung adenocarcinoma, thyroid cancer and gastrointestinal tract cancer respectively. CD10, Vimentin and RCC were all positive and all are specific for renal cell carcinoma. The diagnosis was renal cell carcinoma, papillary cell type. Sunitinib, a tyrosine kinase inhibitor, is the treatment of choice for renal cell carcinoma since it improves objective response rate and shows longer progression free survival than IFNα.doi: http://dx.doi.org/10.4021/wjon593w
机译:肾细胞癌是泰国罕见的癌症。大多数患者处于晚期转移期,并伴有可识别的肾脏肿块。在本病例报告中,我们介绍了一例男性患者,表现为锁骨上淋巴结肿大,胸部和腹部的CT扫描显示有多个部位淋巴结转移,但在任何地方均未检测到原发肿块。锁骨上淋巴结的病理是乳头状细胞腺癌。鉴别诊断为甲状腺乳头状癌,胃肠道癌如胰胆管癌,非小细胞肺癌和肾癌。 TTF-1,甲状腺球蛋白,CD7和CD20的免疫组织化学结果均为阴性,分别排除了非小细胞肺腺癌,甲状腺癌和胃肠道癌。 CD10,波形蛋白和RCC均为阳性,并且都对肾细胞癌具有特异性。诊断为肾细胞癌,乳头状细胞类型。舒尼替尼是一种酪氨酸激酶抑制剂,是肾细胞癌的首选治疗方法,因为它比IFNα改善了客观应答率并显示出更长的无进展生存期。doi:http://dx.doi.org/10.4021/wjon593w

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号